
    
      A total of up to 20 diabetic patients with critic ischemia of lower limbs will be included in
      the study. Patients will be administered with CD133+ cells, that previously have been
      obtained of their peripheral blood after mobilization with G-CSF

      The study is divided in three phases:

      Pre-treatment (previous 4 weeks of CD133+ cells mobilization). Treatment (cells mobilization,
      CD133+ transplant, 24 hours after infusion visit, 4, 12 and 24 weeks after transplant visits)
      Follow-up (9 and 12 months after transplant visits)
    
  